Pfizer, Merck, Regeneron: Covid Treatment Stocks Back In Focus As Infections Soar - 1breakingnews.co
Our indicative theme on Covid-19 Treatment Stocks – which includes biotech and pharma companies selling or developing treatments for the Covid-19 virus – is up by 25% year-to-date, compared to the S&P 500 which is up about 26% over the same period.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews
Category
🗞
News